MX2016005825A - Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon. - Google Patents
Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon.Info
- Publication number
- MX2016005825A MX2016005825A MX2016005825A MX2016005825A MX2016005825A MX 2016005825 A MX2016005825 A MX 2016005825A MX 2016005825 A MX2016005825 A MX 2016005825A MX 2016005825 A MX2016005825 A MX 2016005825A MX 2016005825 A MX2016005825 A MX 2016005825A
- Authority
- MX
- Mexico
- Prior art keywords
- test results
- blood
- evaluating
- lung cancer
- blood test
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Theoretical Computer Science (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Ecology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Physiology (AREA)
Abstract
Un procedimiento para evaluar el riesgo de cáncer de pulmón mediante la generación de un conjunto de características que comprenden una pluralidad de resultados actuales de análisis de sangre de una sangre extraída de un individuo diana, proporcionando al menos un clasificador generado de acuerdo con un análisis de una pluralidad de resultados históricos de análisis de sangre respectivos de cada uno de otra pluralidad de individuos sometidos a muestreo, y evaluar, usando un procesador, un riesgo de cáncer de pulmón de dicho individuo diana mediante la clasificación de dicho conjunto de características usando dicho al menos un clasificador. Cada una de dicha pluralidad de resultados de análisis de sangre históricos y actuales comprende resultados de uno o más análisis de sangre seleccionados tales como resultados de análisis de sangre glóbulos blancos, resultados del análisis de bioquímica, resultados del análisis de sangre plaquetario que incluye al menos uno de recuento plaquetario y volumen plaquetario medio (VPM) y/o una combinación de historia de tabaquismo y resultados de análisis de glóbulos rojos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361901059P | 2013-11-07 | 2013-11-07 | |
PCT/IL2014/050960 WO2015068157A1 (en) | 2013-11-07 | 2014-11-05 | Methods and systems of evaluating a risk of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016005825A true MX2016005825A (es) | 2016-12-09 |
Family
ID=53040982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005825A MX2016005825A (es) | 2013-11-07 | 2014-11-05 | Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon. |
Country Status (11)
Country | Link |
---|---|
US (2) | US11031105B2 (es) |
EP (1) | EP3065630B1 (es) |
JP (1) | JP6645703B2 (es) |
KR (1) | KR102310799B1 (es) |
CN (1) | CN105814571B (es) |
AU (1) | AU2014347669C1 (es) |
BR (1) | BR112016010322A2 (es) |
CA (1) | CA2928271C (es) |
MX (1) | MX2016005825A (es) |
RU (1) | RU2677742C2 (es) |
WO (1) | WO2015068157A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014186036A1 (en) | 2013-03-14 | 2014-11-20 | Allegro Diagnostics Corp. | Methods for evaluating copd status |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
BR112016010322A2 (pt) | 2013-11-07 | 2017-08-08 | Medial Res Ltd | Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão |
EP3770274A1 (en) | 2014-11-05 | 2021-01-27 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
CN105232060A (zh) * | 2015-08-31 | 2016-01-13 | 陈琼 | 基于独立风险因子组合筛查的预警系统 |
CN106974660B (zh) * | 2017-04-20 | 2020-03-06 | 重庆邮电大学 | 基于脑功能活动检测中的血氧特征实现性别判定的方法 |
CN107133475B (zh) * | 2017-05-10 | 2020-09-29 | 浙江省立同德医院 | 一种中药注射剂不良反应高危患者模式识别方法 |
JP2020522690A (ja) * | 2017-06-02 | 2020-07-30 | ベラサイト インコーポレイテッド | 肺疾病の特定又はモニタリング方法及びシステム |
US11657593B2 (en) * | 2017-07-28 | 2023-05-23 | Siemens Healthcare Diagnostics Inc. | Deep learning volume quantifying methods and apparatus |
CN108245161A (zh) * | 2017-12-26 | 2018-07-06 | 北京医拍智能科技有限公司 | 肺部常见疾病的辅助诊断系统 |
CN108717867A (zh) * | 2018-05-02 | 2018-10-30 | 中国科学技术大学苏州研究院 | 基于梯度迭代树的疾病预测模型建立方法及装置 |
CN109585011A (zh) * | 2018-10-26 | 2019-04-05 | 朱海燕 | 胸痛患者的病症诊断方法及机器可读存储介质 |
CN110825819A (zh) * | 2019-09-24 | 2020-02-21 | 昆明理工大学 | 一种处理有缺失值和不平衡非小细胞肺癌数据的二分类方法 |
KR102487864B1 (ko) * | 2020-02-10 | 2023-01-11 | 연세대학교 원주산학협력단 | 지역사회획득폐렴 환자의 예후를 예측하는 방법 및 이를 위한 예측시스템 |
CN111933287A (zh) * | 2020-06-24 | 2020-11-13 | 四川省肿瘤医院 | 整合血液和富含血小板血浆中的血小板特征建立肺癌模型 |
CN114663330A (zh) * | 2020-12-03 | 2022-06-24 | 富泰华工业(深圳)有限公司 | 干细胞密度确定方法、装置、电子设备及存储介质 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733354A (en) * | 1984-11-23 | 1988-03-22 | Brian Potter | Method and apparatus for automated medical diagnosis using decision tree analysis |
AU1837495A (en) * | 1994-10-13 | 1996-05-06 | Horus Therapeutics, Inc. | Computer assisted methods for diagnosing diseases |
US5687716A (en) * | 1995-11-15 | 1997-11-18 | Kaufmann; Peter | Selective differentiating diagnostic process based on broad data bases |
US6059724A (en) | 1997-02-14 | 2000-05-09 | Biosignal, Inc. | System for predicting future health |
WO2002087431A1 (en) * | 2001-05-01 | 2002-11-07 | Structural Bioinformatics, Inc. | Diagnosing inapparent diseases from common clinical tests using bayesian analysis |
CN101180408A (zh) | 2005-05-19 | 2008-05-14 | 西尼尔根茨生物科学有限公司 | 用遗传多态性分析评估发生肺癌的风险的方法 |
US20070118399A1 (en) * | 2005-11-22 | 2007-05-24 | Avinash Gopal B | System and method for integrated learning and understanding of healthcare informatics |
US9347945B2 (en) * | 2005-12-22 | 2016-05-24 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
CA2821426A1 (en) * | 2005-12-22 | 2007-07-05 | Abbott Laboratories | Methods and marker combinations for screening for predisposition to lung cancer |
CA2681667A1 (en) * | 2007-05-18 | 2008-11-27 | Duke University | Serum biomarkers for the early detection of lung cancer |
WO2009065230A1 (en) * | 2007-11-23 | 2009-05-28 | British Columbia Cancer Agency Branch | Methods for detecting lung cancer and monitoring treatment response |
ES2559758T3 (es) * | 2008-09-09 | 2016-02-15 | Somalogic, Inc. | Biomarcadores de cáncer de pulmón y usos de los mismos |
US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
CA2801110C (en) * | 2010-07-09 | 2021-10-05 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
GB201021289D0 (en) * | 2010-12-15 | 2011-01-26 | Immatics Biotechnologies Gmbh | Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
RU2011135615A (ru) * | 2011-08-26 | 2013-03-10 | Михаил Владимирович Кутушов | Способ диагностики онкологических и соматических заболеваний |
BR112016010322A2 (pt) | 2013-11-07 | 2017-08-08 | Medial Res Ltd | Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão |
-
2014
- 2014-11-05 BR BR112016010322A patent/BR112016010322A2/pt not_active Application Discontinuation
- 2014-11-05 CN CN201480067921.8A patent/CN105814571B/zh active Active
- 2014-11-05 WO PCT/IL2014/050960 patent/WO2015068157A1/en active Application Filing
- 2014-11-05 US US15/035,232 patent/US11031105B2/en active Active
- 2014-11-05 RU RU2016121682A patent/RU2677742C2/ru active
- 2014-11-05 MX MX2016005825A patent/MX2016005825A/es unknown
- 2014-11-05 CA CA2928271A patent/CA2928271C/en active Active
- 2014-11-05 KR KR1020167014533A patent/KR102310799B1/ko active IP Right Grant
- 2014-11-05 EP EP14859375.9A patent/EP3065630B1/en active Active
- 2014-11-05 JP JP2016526346A patent/JP6645703B2/ja active Active
- 2014-11-05 AU AU2014347669A patent/AU2014347669C1/en active Active
-
2021
- 2021-06-07 US US17/340,137 patent/US20210295960A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20160079086A (ko) | 2016-07-05 |
RU2016121682A (ru) | 2017-12-11 |
EP3065630A1 (en) | 2016-09-14 |
RU2016121682A3 (es) | 2018-06-22 |
US11031105B2 (en) | 2021-06-08 |
JP6645703B2 (ja) | 2020-02-14 |
AU2014347669B2 (en) | 2019-11-21 |
AU2014347669C1 (en) | 2021-03-11 |
BR112016010322A2 (pt) | 2017-08-08 |
CA2928271C (en) | 2022-05-31 |
EP3065630B1 (en) | 2020-09-09 |
CN105814571B (zh) | 2020-01-07 |
JP2016535262A (ja) | 2016-11-10 |
US20210295960A1 (en) | 2021-09-23 |
AU2014347669A1 (en) | 2016-06-23 |
CA2928271A1 (en) | 2015-05-14 |
KR102310799B1 (ko) | 2021-10-12 |
US20160292379A1 (en) | 2016-10-06 |
EP3065630A4 (en) | 2017-07-19 |
RU2677742C2 (ru) | 2019-01-21 |
CN105814571A (zh) | 2016-07-27 |
WO2015068157A1 (en) | 2015-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016005825A (es) | Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon. | |
MX347850B (es) | Métodos y sistemas para evaluar un riesgo de un cáncer gastrointestinal. | |
MX2016016902A (es) | Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas. | |
CY1118694T1 (el) | Μεθοδοι διαχωρισμου σωματιδιων χρησιμοποιωντας μια συσκευη με ενα στοιχειο διαχωρισμου με διακριση μεγεθους που εχει μια επιμηκη αιχμη | |
CA3010517A1 (en) | Method for evaluating the health status of an individual | |
IN2014DN10974A (es) | ||
WO2014152039A3 (en) | Operatorless particle processing systems and methods | |
WO2015102919A3 (en) | Modular image analysis system and method | |
GB2532672A (en) | Methods and systems for analysis of organ transplantation | |
EA201591350A1 (ru) | Системы и способы усовершенствования прямого численного моделирования свойств материала из образцов горной породы и выявления неопределенности в свойствах материала | |
MX2016013984A (es) | Sistema y metodo de deteccion de hemolisis. | |
NZ621733A (en) | Lung cancer biomarkers and uses thereof | |
TR201904387T4 (tr) | Elektrikle çalışan sigara içim cihazları için arıza tanısı aparatı. | |
WO2012139047A3 (en) | Identifying and enumerating early granulated cells (egcs) | |
JP2013036832A5 (es) | ||
PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
MX2016000293A (es) | Biomarcadores del trastrono del espectro autista. | |
Konst et al. | Exploration of the correlation between autism spectrum disorder symptomology and tantrum behaviors. | |
EP2784479A3 (en) | Blood cell analyzer and blood cell analyzing method | |
BR102012002812A8 (pt) | método para determinar a influência de uma variável em um fenômeno | |
NZ630388A (en) | High efficiency methods of sex sorting sperm | |
MX2015012319A (es) | Sistemas de instrumento analitico. | |
MX2015009649A (es) | Sistema y metodo para cuantificar zooplancton. | |
WO2018097614A3 (ko) | 유방암 환자의 화학치료 유용성 예측 방법 | |
WO2015188114A3 (en) | Predicting morbidity associated with red blood cell volume variance |